Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
University of Rochester
Institut Paoli-Calmettes
Massachusetts General Hospital
Roswell Park Cancer Institute
Gamida Cell ltd
M.D. Anderson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)
Prelude Therapeutics
University of Nebraska
Massachusetts General Hospital
Brown University
Ohio State University Comprehensive Cancer Center
Center for International Blood and Marrow Transplant Research
Centre Henri Becquerel
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
University of Arizona
M.D. Anderson Cancer Center
Thomas Jefferson University
Takeda
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Constellation Pharmaceuticals
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)
Asan Medical Center
Masonic Cancer Center, University of Minnesota
Stanford University
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Novo Nordisk A/S
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
American Regent, Inc.
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Novartis
Groupe Francophone des Myelodysplasies
Thomas Jefferson University
University of Pittsburgh
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center